Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.7.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2017
Mar. 31, 2016
CURRENT ASSETS    
Cash $ 1,559,701 $ 2,123,737
Accounts receivable 0 199,471
Prepaid expenses and other current assets 37,551 53,294
TOTAL CURRENT ASSETS 1,597,252 2,376,502
Property and equipment, net 29,223 36,038
Patents, net 84,996 94,161
Deposits 14,897 22,415
TOTAL ASSETS 1,726,368 2,529,116
CURRENT LIABILITIES    
Accounts payable 484,423 244,804
Due to related parties 57,866 145,112
Other current liabilities 69,467 136,695
TOTAL CURRENT LIABILITIES 611,756 526,611
Convertible notes payable, net 519,200 500,139
TOTAL LIABILITIES 1,130,956 1,026,750
COMMITMENTS AND CONTINGENCIES (Note 12)
STOCKHOLDERS' EQUITY    
Common stock, $0.001 par value, 30,000,000 shares authorized at March 31, 2017 and 2016; 8,797,086 and 7,622,393 issued and outstanding at March 31, 2017 and 2016, respectively 8,796 7,621
Additional paid-in capital 94,445,739 88,047,142
Accumulated deficit (93,778,156) (86,502,043)
TOTAL AETHLON MEDICAL, INC STOCKHOLDERS' EQUITY BEFORE NONCONTROLLING INTERESTS 676,379 1,552,720
NONCONTROLLING INTERESTS (80,967) (50,354)
TOTAL STOCKHOLDERS' EQUITY 595,412 1,502,366
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 1,726,368 $ 2,529,116